R H Creech - JoVE Visualize

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

Cancer Treatment Reports|September 1, 1984

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579)R H Creech, D Tritchler, D S Ettinger, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.

American Journal of Clinical Oncology|April 1, 1983

A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group StudyD S Ettinger, R Day, J A Ferraro, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancerJ C Ruckdeschel, D M Finkelstein, D S Ettinger, et al.

Cancer|December 1, 1982

Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neckS E Vogl, D A Schoenfeld, B H Kaplan, et al.

Progress in Clinical and Biological Research|January 1, 1983

Research in cancer patient education and complianceW L Jones, H H Dayal, P L Grover, et al.

Cancer Treatment Reports|October 1, 1987

Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.

Cancer|November 1, 1987

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG studyG Falkson, L M Ryan, L A Johnson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.

Investigational New Drugs|January 1, 1987

Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanomaD A Amato, H Bruckner, D Guerry, et al.

Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

Cancer Treatment Reports|September 1, 1984

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579)R H Creech, D Tritchler, D S Ettinger, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.

American Journal of Clinical Oncology|April 1, 1983

A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group StudyD S Ettinger, R Day, J A Ferraro, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancerJ C Ruckdeschel, D M Finkelstein, D S Ettinger, et al.

Cancer|December 1, 1982

Methotrexate alone or with regional subcutaneous Corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neckS E Vogl, D A Schoenfeld, B H Kaplan, et al.

Progress in Clinical and Biological Research|January 1, 1983

Research in cancer patient education and complianceW L Jones, H H Dayal, P L Grover, et al.

Cancer Treatment Reports|October 1, 1987

Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.

Cancer|November 1, 1987

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG studyG Falkson, L M Ryan, L A Johnson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomasE C Borden, D A Amato, C Rosenbaum, et al.

Investigational New Drugs|January 1, 1987

Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanomaD A Amato, H Bruckner, D Guerry, et al.

Pageof 4